Essex Investment Management’s Streamline Health Solutions STRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-107
Closed -$3K 422
2022
Q4
$3K Hold
107
﹤0.01% 391
2022
Q3
$2K Hold
107
﹤0.01% 410
2022
Q2
$2K Buy
+107
New +$2.15K ﹤0.01% 421
2015
Q4
Sell
-999
Closed -$34K 330
2015
Q3
$34K Buy
+999
New +$40.3K 0.01% 314
2014
Q1
Sell
-17,399
Closed -$1.82M 369
2013
Q4
$1.82M Buy
17,399
+4,164
+31% +$458K 0.26% 114
2013
Q3
$1.51M Buy
13,235
+4,315
+48% +$472K 0.23% 123
2013
Q2
$879K Buy
+8,920
New +$874K 0.16% 165

Other funds holding STRM

Essex Investment Management's STRM Position: Q1 2023 in Review

Essex Investment Management sold out of Streamline Health Solutions (STRM) in Q1 2023, closing a stake of 107 shares — an estimated $3K sold.

Essex Investment Management first reported a position in STRM in Q2 2013 and held it in 7 quarters. The position peaked at $1.82M in Q4 2013. 37 funds tracked by Wall St. Rank hold STRM as of Q1 2023.

  • Essex Investment Management reported no remaining Streamline Health Solutions position as of Q1 2023 after selling out during the quarter.
  • Essex Investment Management sold 107 Streamline Health Solutions shares in Q1 2023, an estimated $3K.
  • Essex Investment Management first reported a position in Streamline Health Solutions in Q2 2013 and held it in 7 quarters.
  • Essex Investment Management's Streamline Health Solutions position peaked at $1.82M in Q4 2013.
  • 37 funds tracked by Wall St. Rank held Streamline Health Solutions as of Q1 2023.

Based on Essex Investment Management's 13F filing for Q1 2023, filed 4 May 2023.